Christopher B. Damoci

Christopher Damoci is Manager of the Columbia University Oncology Precision Therapeutics Imaging Core (OPTIC) at the Herbert Irving Comprehensive Cancer Center.  Chris received his Bachelor’s from Fairleigh Dickinson University in 2001 and worked at the Garden State Cancer Center and the Center for Molecular Medicine and Immunology. Chris moved to ImClone Systems and then Eli Lilly focusing of preclinical experimental therapeutics in their monoclonal antibody platforms and is very proud to have been part of the teams that brought a number of breakthrough drugs to market, specifically Erbitux (Cetuximab) and Cyramza (Ramucirumab).  Chris joined Columbia in 2004 and loves his position here at Columbia University where he gets to teach the next generations of research scientists throughout the Herbert Irving Comprehensive Cancer Center the benefits of noninvasive imaging like MRI, CT, Ultrasound and Optical for their ongoing research.